Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Sell

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Neutral

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Athira Pharma, Inc. Common Stock (ATHA)

Biological Products, (no Disgnostic Substances)

https://www.athira.com

Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) a subcutaneously administered, small molecule positive modulator of the HGF/MET system for CNS disorders, ATH-1020 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system. ATH-1105 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system, and several other compounds in preclinical discovery and development for neurodegenerative diseases, including ATH-1018 and ATH-1019.

18706 NORTH CREEK PARKWAY, SUITE 104
BOTHELL, WA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

09/18/2020

Market Cap

115,702,594

Shares Outstanding

38,060,000

Weighted SO

38,054,583

Total Employees

N/A

Upcoming Earnings

08/08/2024

Beta

2.9120

Last Div

0.0000

Range

1.33-4.298

Chg

0.0200

Avg Vol

122485

Mkt Cap

115702594

Exch

NASDAQ

Country

US

Phone

425 620 8501

DCF Diff

0.6492

DCF

2.3408

Div Yield

0.0000

P/S

69.8687

EV Multiple

-0.2893

P/FV

1.3862

Div Yield %

0.0000

P/E

-1.0183

PEG

0.0302

Payout

0.0000

Current Ratio

3.9664

Quick Ratio

3.9664

Cash Ratio

3.0556

DSO

358.8285

DIO

0.0000

Op Cycle

358.8285

DPO

178.1860

CCC

180.6425

Gross Margin

0.4124

Op Margin

-73.3086

Pretax Margin

-68.5091

Net Margin

-68.5091

Eff Tax Rate

-0.0189

ROA

-1.0198

ROE

-0.9553

ROCE

-1.4392

NI/EBT

1.0000

EBT/EBIT

0.9345

EBIT/Rev

-73.3086

Debt Ratio

0.0126

D/E

0.0169

LT Debt/Cap

0.0120

Total Debt/Cap

0.0166

Int Coverage

-62.2559

CF/Debt

-69.9439

Equity Multi

1.3350

Rec Turnover

1.0172

Pay Turnover

2.0484

Inv Turnover

0.0000

FA Turnover

0.4287

Asset Turnover

0.0149

OCF/Share

-2.5641

FCF/Share

-2.5658

Cash/Share

2.6092

OCF/Sales

-59.4269

FCF/OCF

1.0006

CF Coverage

-69.9439

ST Coverage

-251.6905

CapEx Coverage

-1562.0794

Div&CapEx Cov

-1562.0794

P/BV

1.3862

P/B

1.3862

P/S

69.8687

P/E

-1.0183

P/FCF

-1.1750

P/OCF

-1.1739

P/CF

-1.1739

PEG

0.0302

P/S

69.8687

EV Multiple

-0.2893

P/FV

1.3862

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation